Brief: Biosynex Says 2020 Sales To Be Boosted By COVID-19 Tests

Biosynex SA

16/06/2020 17:15

June 16 (Reuters) - Biosynex SA  ALBIO.PA :
    * ANTICIPATES CONTINUED STRONG ACTIVITY IN THE COMING MONTHS
DRIVEN BY THE COMMERCIALIZATION OF COVID-19 RAPID DIAGNOSTIC
TESTS
    * SALES OF €34M AT THE END OF MAY VERSUS €34.2M OVER 12
MONTHS IN
2019
    * SALES IN 2020 SHOULD CONTINUE TO BENEFIT FROM THE RAMP-UP
OF
COVID-19 SCREENING TESTS, PARTICULARLY IN NORTH AND SOUTH
AMERICA
    * GIVEN THE IMPACT OF CONTAINMENT ON POPULATIONS, SALES OF
OTHER
TESTS (HIV, ANGINA, ETC.) REMAIN STABLE VERSUS LAST YEAR

Source text for Eikon:  ID:nBw4FDnpfa 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))